Depression and anxiety are increasingly common conditions for which primary care providers (PCPs) serve as the initial healthcare contact for most patients. Comorbid depression and anxiety result in higher costs, and treatment as usual, which is referrals to specialty psychiatric care, often contribute to delays in care. Collaborative psychiatric care is an evidence-based strategy to increase mental healthcare access while reducing costs. ADAPT is a novel collaborative care model. By using technology-driven appointments with providers, ADAPT increases access to mental healthcare, and reduces member wait times. This mixed methods study will assess implementation measures of the ADAPT program and the components of ADAPT related to patient mental health improvement compared to specialty mental health care. The hypothesis is that: ADAPT program will have good program reach and efficacy. We will examine program implementation and maintenance. Further, the study looks to uncover member and program characteristics that are associated with depression and anxiety remission and care utilization.
Study Type
OBSERVATIONAL
The Achieving Depression and Anxiety Patient Centered Treatment (ADAPT) Program is a novel collaborative psychiatric care model that is designed to unburden PCPs and psychiatrists, increase access to quality specialty mental healthcare for Kaiser Permanente members, and improve patient depression and anxiety treatment outcomes by utilizing technology-driven appointments. This program uses principles of collaborative care, including patient-centered care, population-based care, evidence-based care, measurement-based treatment to target, and accountable care.
Kaiser Permanente Northern California Division of Research
Oakland, California, United States
Patient reach
Examine and compare patients eligible and enrolled in ADAPT versus those eligible but not enrolled in ADAPT
Time frame: through study completion, 2 years
Member characteristics associated with depression remission
Clinical variables important to predicting intervention response: Patient demographics (age, sex, race/ethnicity, socioeconomic status), behavioral characteristics (exercise, sleep), and other individual characteristics (comorbidities, adverse childhood experiences, social supports, resilience).
Time frame: baseline, 3 and 6 months
Member characteristics associated with anxiety remission
Clinical variables important to predicting intervention response: Patient demographics (age, sex, race/ethnicity, socioeconomic status), behavioral characteristics (exercise, sleep), and other individual characteristics (comorbidities, adverse childhood experiences, social supports, resilience).
Time frame: baseline, 3 and 6 months
Efficacy: Patient therapy engagement
number of therapy contacts (individual, group and combined)
Time frame: baseline, 3 and 6 months
Efficacy: Patient medication provider engagement
number of clinical pharmacy contacts
Time frame: baseline, 3 and 6 months
Efficacy: Patient medication engagement
medication length of treatment
Time frame: baseline, 3 and 6 months
Efficacy: Patient psychiatry engagement
number of contact with psychiatrist
Time frame: baseline, 3 and 6 months
Efficacy: Patient time to care
average time from ADAPT referral to first appointment with therapist or pharmacist
Time frame: baseline, 3 and 6 months
Efficacy: Depression outcomes
Examine if patients enrolled in ADAPT demonstrate non-inferior depression outcomes defined by change in the patient health questionnaire (PHQ-9) score compared to treatment as usual.
Time frame: baseline, 3 and 6 months
Efficacy: Anxiety outcomes
Examine if patients enrolled in ADAPT demonstrate non-inferior anxiety outcomes defined by generalized anxiety disorder (GAD-2) score compared to treatment as usual.
Time frame: baseline, 3 and 6 months
Efficacy: Time to clinical improvement
Compare time to clinical improvement as defined by change in Adult Outcomes Questionnaire (AOQ score) from baseline to 3, and 6 months for members in ADAPT compared to treatment as usual.
Time frame: baseline, 3 and 6 months
Implementation: measurement-based care
Examine provider use of measurement-based care
Time frame: through study completion, 2 years
Implementation: Diagnosis
Examine provider use of a specific depression or anxiety diagnosis
Time frame: through study completion, 2 years
Maintenance: Measurement-based care
Examine provider use of measurement-based care over time
Time frame: through study completion, 2 years
Maintenance: Diagnosis
Examine provider use of a specific depression or anxiety diagnosis over time
Time frame: through study completion, 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.